Skip to Content

Olux-E Approval History

FDA Approved: Yes (First approved January 12, 2007)
Brand name: Olux-E
Generic name: clobetasol propionate
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Psoriasis, Eczema

Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.

Development History and FDA Approval Process for Olux-E

DateArticle
Jan 12, 2007Approval Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide